Joe Flanagan - Accustem Sciences Chief Officer
| ACUT Stock | USD 0.36 0.03 9.09% |
Insider
Joe Flanagan is Chief Officer of Accustem Sciences
| Age | 49 |
| Web | https://www.accustem.com |
Accustem Sciences Management Team
Elected by the shareholders, the Accustem Sciences' board of directors comprises two types of representatives: Accustem Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accustem. The board's role is to monitor Accustem Sciences' management team and ensure that shareholders' interests are well served. Accustem Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accustem Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeff Fensterer, Chief Officer | ||
| Joe Flanagan, Chief Officer | ||
| Wendy Blosser, CEO Director |
Accustem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Accustem Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Owned By Insiders | 45.00 % |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Accustem OTC Stock Analysis
When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.